This statistic depicts the number of active clinical trials for drugs with symptom-modifying potential for Alzheimer's disease in 2019, by strategy. At that time there were 14 drugs in trials that utilized acetylocholine, a neurotransmitter, to treat the symptoms of Alzheimer's disease.
Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization. (May 14, 2019). Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. "Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy." Chart. May 14, 2019. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. (2019). Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization. "Total Number of Global Clinical Trials for Novel Symptom-modifying Drugs for Alzheimer's Disease in Early 2019, by Strategy." Statista, Statista Inc., 14 May 2019, https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/
Biotechnology Innovation Organization, Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy Statista, https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/ (last visited November 21, 2024)
Total number of global clinical trials for novel symptom-modifying drugs for Alzheimer's disease in early 2019, by strategy [Graph], Biotechnology Innovation Organization, May 14, 2019. [Online]. Available: https://www.statista.com/statistics/1029709/alzheimers-symptom-modifying-drug-global-clinical-trials-by-strategy/
